Veltassa FDA Approval History
FDA Approved: Yes (First approved October 21, 2015)
Brand name: Veltassa
Generic name: patiromer
Dosage form: for Oral Suspension
Company: Vifor Pharma, Inc.
Treatment for: Hyperkalemia
Veltassa (patiromer) is an oral potassium binder for the treatment of hyperkalemia.
Development timeline for Veltassa
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.